Pietro Lampertico

Pietro Lampertico

UNVERIFIED PROFILE

Are you Pietro Lampertico?   Register this Author

Register author
Pietro Lampertico

Pietro Lampertico

Publications by authors named "Pietro Lampertico"

Are you Pietro Lampertico?   Register this Author

100Publications

2140Reads

17Profile Views

Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation.

Transplantation 2020 Mar;104(3):568-574

CRC "A. M. and A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000002955DOI Listing
March 2020

Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B.

Liver Int 2020 Mar 7;40(3):484-495. Epub 2020 Jan 7.

Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.14334DOI Listing
March 2020

Ribavirin as a beneficial treatment option for hepatitis C virusassociated glomerular disease.

Saudi J Kidney Dis Transpl 2020 Jan-Feb;31(1):109-117

Division of Nephrology, Maggiore Hospital and IRCCS Foundation; Deparment of Medicine, University School of Medicine, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/1319-2442.279930DOI Listing
March 2020

Reply to: "Clinical relevance of dynamic risk assessment for developing hepatocellular carcinoma during prolonged antiviral therapy".

J Hepatol 2020 Mar 27. Epub 2020 Mar 27.

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico - Division of Gastroenterology and Hepatology - CRC "A. M. and A. Migliavacca" Center for Liver Disease, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2020.03.014DOI Listing
March 2020

Epidemiology and surveillance for hepatocellular carcinoma: New trends.

J Hepatol 2020 Feb;72(2):250-261

Centre de Recherche des Cordeliers, Sorbonne Universités, Université Paris Descartes, Université Paris Diderot, Université Paris, Paris, France; Functional Genomics of Solid Tumors, USPC, Université Paris Descartes, Université Paris Diderot, Université Paris, Paris, France; Service d'hépatologie, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bondy, France; Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris 13, Communauté d'Universités et Etablissements Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.08.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986771PMC
February 2020

Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.

J Hepatol 2020 Jan 23;72(1):34-44. Epub 2019 Jul 23.

Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore; Singapore Immunology Network, Singapore Agency for Science, Technology & Research (A*STAR), Singapore, Singapore. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.07.015DOI Listing
January 2020

Is Tenofovir Superior to Entecavir in Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B? The Controversy Continues.

Gastroenterology 2020 01 7;158(1):42-44. Epub 2019 Nov 7.

Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.11.007DOI Listing
January 2020

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?

Hepatol Commun 2020 Jan 2;4(1):5-7. Epub 2020 Jan 2.

CRC "A.M. and A. Migliavacca" Center for the Study of Liver Disease Division of Gastroenterology and Hepatology Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Università degli Studi di Milano Milan Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep4.1476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939499PMC
January 2020

Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis.

Liver Int 2019 Dec 30;39(12):2309-2316. Epub 2019 Aug 30.

Unit of Medicine and Metabolic Diseases, Pathophysiology and Transplantation Department, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.14213DOI Listing
December 2019

Nucleos(t)ide Analog Therapy of Chronic Hepatitis B and Liver Cancer Risk Reduction: Better Nucleotides than Nucleosides?

Gastroenterology 2019 12 14;157(6):1682-1684. Epub 2019 Oct 14.

Department of Medicine, Humanitas Hospital, Rozzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.10.011DOI Listing
December 2019

Focus on Very Late Hepatocellular Carcinoma Recurring After Liver Transplantation: A Case Report and Literature Review.

Transplant Proc 2019 Nov 10;51(9):2998-3000. Epub 2019 Oct 10.

Division of General Surgery and Liver Transplantation, IRCCS Foundation, Ca' Granda Maggiore Hospital, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2019.04.095DOI Listing
November 2019

TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals.

J Viral Hepat 2019 Oct 30;26(10):1233-1236. Epub 2019 Jun 30.

CRC "A. M. e A. Migliavacca" Center for Liver Diseases, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jvh.13155DOI Listing
October 2019

Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients.

J Hepatol 2019 Oct 11;71(4):834-839. Epub 2019 Jul 11.

CRC "A. M. and A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.07.003DOI Listing
October 2019

Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy.

Liver Int 2019 Oct 12;39(10):1964-1974. Epub 2019 Aug 12.

CRC 'A. M. and A. Migliavacca' Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.14197DOI Listing
October 2019

An easy-to-use baseline scoring system to predict response to peginterferon alfa-2a in patients with chronic hepatitis B in resource-limited settings.

Antivir Ther 2018 ;23(8):655-663

Service d'Hépatologie Chief and Viral Hepatitis Team, INSERM UMR 1149, Centre de Recherche sur l'Inflammation, Paris Diderot University, Hôpital Beaujon, Clichy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3251DOI Listing
September 2019

Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB - Is one NUC better than the other?

J Hepatol 2019 Sep 14;71(3):453-455. Epub 2019 Jun 14.

CRC "A. M. and A. Migliavacca" Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.05.017DOI Listing
September 2019

Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.

Dig Liver Dis 2019 08 11;51(8):1135-1140. Epub 2019 Jan 11.

CRC "A. M. e A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.12.025DOI Listing
August 2019

Impact of hepatitis C virus and direct acting antivirals on kidney recipients: a retrospective study.

Transpl Int 2019 May 11;32(5):493-501. Epub 2019 Jan 11.

Unit of Nephrology, Dialysis and Renal Transplant, Department of Medicine, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/tri.13393
Publisher Site
http://dx.doi.org/10.1111/tri.13393DOI Listing
May 2019

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.

Clin Gastroenterol Hepatol 2019 05 26;17(6):1183-1191.e7. Epub 2018 Oct 26.

CRC "A. M. e A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.10.038DOI Listing
May 2019

Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.

J Hepatol 2019 Apr 7;70(4):615-625. Epub 2018 Dec 7.

INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, UMR_S1052, CRCL, 69008 Lyon, France; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278183258
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2018.11.030DOI Listing
April 2019

Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients.

Kidney Int 2019 04;95(4):993-995

CRC "A.M. and A. Migliavacca" Center for Liver Disease, Gastroenterology and Hepatology Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2018.11.037DOI Listing
April 2019

Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.

Dig Liver Dis 2019 03 7;51(3):419-424. Epub 2018 Sep 7.

CRC "A. M. and A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.08.024DOI Listing
March 2019

Hepatitis D - how is the fight against this foe going?

Expert Rev Clin Pharmacol 2019 Mar 6;12(3):169-171. Epub 2019 Feb 6.

a CRC "A. M. and A. Migliavacca" Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology , Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano , Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17512433.2019.1
Publisher Site
http://dx.doi.org/10.1080/17512433.2019.1577135DOI Listing
March 2019

Hepatitis C virus-induced glomerular disease and posterior reversible encephalopathy syndrome after liver transplant: Case report and literature review.

Saudi J Kidney Dis Transpl 2019 Jan-Feb;30(1):239-249

Division of Nephrology, Maggiore Hospital and IRCCS Foundation; School of Medicine, University of Milano, Milano, Italy.

View Article

Download full-text PDF

Source
February 2019

Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations.

Liver Int 2018 09 15;38(9):1624-1634. Epub 2018 Jul 15.

Division of Gastroenterology and Hepatology, CRC "A.M. and A. Migliavacca" Center for the study of Liver Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13888DOI Listing
September 2018

[Direct-acting antiviral agents, hepatitis C and dialysis: an update].

G Ital Nefrol 2018 Sep;35(5)

Divisione Nefrologia, Ospedale Maggiore e Fondazione IRCCS, e Università degli Studi di Milano, Italia.

View Article

Download full-text PDF

Source
September 2018

Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression.

Liver Int 2018 08 12;38(8):1459-1467. Epub 2018 Mar 12.

A. M. and A. Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13707DOI Listing
August 2018

Less can be more: A finite treatment approach for HBeAg-negative chronic hepatitis B.

Hepatology 2018 08 14;68(2):397-400. Epub 2018 May 14.

Section of Hepatology Clinic and Polyclinic for Gastroenterology and Rheumatology, University Clinic Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.29821DOI Listing
August 2018

High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis.

Eur J Clin Pharmacol 2018 Aug 18;74(8):1089-1090. Epub 2018 Apr 18.

Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, University Hospital, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-018-2462-0DOI Listing
August 2018

12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis.

Dig Liver Dis 2018 07 12;50(7):703-706. Epub 2018 Feb 12.

CRC "A. M.e A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.02.003DOI Listing
July 2018

A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B.

Ann Gastroenterol 2018 Nov-Dec;31(6):712-721. Epub 2018 Jul 26.

Department of Gastroenterology, Medical School of National & Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece (George V. Papatheodoridis).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20524/aog.2018.0300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191871PMC
July 2018

Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up.

Int J Artif Organs 2018 Jun 29;41(6):306-318. Epub 2018 Mar 29.

1 Division of Nephrology, Maggiore Hospital and IRCCS Foundation, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0391398818762358DOI Listing
June 2018

IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.

Liver Int 2018 03 10;38(3):417-423. Epub 2017 Aug 10.

A. M. e A. Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13526DOI Listing
March 2018

Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions?

Expert Rev Anti Infect Ther 2018 02 23;16(2):153-161. Epub 2018 Jan 23.

b CRC "A. M. and A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology , Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14787210.2018.1428561DOI Listing
February 2018

Treatment of hepatitis B: Is there still a role for interferon?

Liver Int 2018 Feb;38 Suppl 1:79-83

CRC "A.M. e A. Migliavacca" Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13635DOI Listing
February 2018

Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports.

Haematologica 2017 10 28;102(10):e423-e426. Epub 2017 Jun 28.

A. M. and A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2017.168609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622877PMC
October 2017

Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance.

J Hepatol 2017 Sep 21. Epub 2017 Sep 21.

"A. M. and A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278173226
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2017.08.020DOI Listing
September 2017

Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.

J Hepatol 2017 05 30;66(5):897-909. Epub 2016 Dec 30.

INSERM U1052-Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, France; University of Lyon, UMR_S1052, CRCL, 69008 Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.12.024DOI Listing
May 2017

Decompensated Cirrhosis and Sickle Cell Disease: Case Reports and Review of the Literature.

Hemoglobin 2017 Mar;41(2):131-133

c Centro per le Malattie Rare, Divisione di Medicina Interna, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico , Università degli Studi di Milano , Milano , Italia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03630269.2017.1341420DOI Listing
March 2017

Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs).

Liver Int 2017 01;37 Suppl 1:45-51

"A.M. e A. Migliavacca" Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13291DOI Listing
January 2017

Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders.

Expert Opin Biol Ther 2016 07 3;16(7):917-26. Epub 2016 May 3.

c A.M. and A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Università di Milano , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2016.1177017DOI Listing
July 2016

Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study.

J Rheumatol 2016 05 15;43(5):869-74. Epub 2016 Feb 15.

From the Rheumatology Unit, Ospedale L. Sacco; Hepatology Unit, Ospedale San Giuseppe, University of Milan; A.M. and A. Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, University of Milan; Rheumatology Day Hospital, Istituto Ortopedico G. Pini, Milan; Rheumatology Unit, Ospedale Mauriziano, Turin; Rheumatology Division, IRCCS Fondazione San Matteo, Università di Pavia, Pavia; University Rheumatology Department, Azienda Ospedaliero Universitaria (AOU) Policlinico, Bari, Italy.V. Varisco*, MD, Rheumatology Unit, Ospedale L. Sacco; M. Viganò*, MD, Hepatology Unit, Ospedale San Giuseppe, University of Milan; A. Batticciotto, MD, PhD, Rheumatology Unit, Ospedale L. Sacco; P. Lampertico, MD, PhD, Professor, A.M. and A. Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan; A. Marchesoni, MD, Rheumatology Day Hospital, Istituto Ortopedico G. Pini; P. Gibertini, MD, Rheumatology Day Hospital, Istituto Ortopedico G. Pini; R. Pellerito, MD, Rheumatology Unit, Ospedale Mauriziano; G. Rovera, MD, Rheumatology Unit, Ospedale Mauriziano; R. Caporali, MD, Professor, Rheumatology Division, IRCCS Fondazione San Matteo, Università di Pavia; M. Todoerti, MD, Rheumatology Division, IRCCS Fondazione San Matteo, Università di Pavia; M. Covelli, MD, University Rheumatology Department, AOU Policlinico; A. Notarnicola, MD, University Rheumatology Department, AOU Policlinico; F. Atzeni, MD, PhD, Rheumatology Unit, Ospedale L. Sacco; P. Sarzi-Puttini, MD, Rheumatology Unit, Ospedale L. Sacco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151105DOI Listing
May 2016

The prognosis and management of inactive HBV carriers.

Liver Int 2016 Jan;36 Suppl 1:100-4

'A. M. and A. Migliavacca' Center for Liver Disease, Division of Gastroenterology and Hepatology Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università di Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://www.aphc.info/wp-content/uploads/2016/01/Paris_manage
Web Search
http://doi.wiley.com/10.1111/liv.13006
Publisher Site
http://dx.doi.org/10.1111/liv.13006DOI Listing
January 2016

The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.

J Hepatol 2015 Nov 19;63(5):1118-25. Epub 2015 Jun 19.

"A.M. and A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.06.006DOI Listing
November 2015

Optimal management of hepatitis B virus infection - EASL Special Conference.

J Hepatol 2015 Nov 3;63(5):1238-53. Epub 2015 Jul 3.

Academic Department of Gastroenterology, Laiko General Hospital, Athens, Greece. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.06.026DOI Listing
November 2015

Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.

Liver Int 2015 Sep 21;35(9):2187-93. Epub 2015 Apr 21.

Gastroenterology and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12835DOI Listing
September 2015

The royal wedding in chronic hepatitis B: The haves and the have-nots for the combination of pegylated interferon and nucleos(t)ide therapy.

Hepatology 2015 May 18;61(5):1459-61. Epub 2015 Mar 18.

A.M.eA. Migliavacca Center for the Study of Liver Disease Division of Gastroenterology and Hepatology Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27731DOI Listing
May 2015

Oral antiviral therapy for HBeAg negative chronic hepatitis B: better stop or continue?

Gut 2015 Apr 20;64(4):526-8. Epub 2014 Aug 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2014-307596DOI Listing
April 2015

Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.

J Hepatol 2015 Apr 13;62(4):956-67. Epub 2015 Jan 13.

1st Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.01.002DOI Listing
April 2015

Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?

Liver Int 2015 Jan;35 Suppl 1:107-13

Hepatology Division, Ospedale San Giuseppe, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12717DOI Listing
January 2015

Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal.

J Clin Virol 2014 Dec 5;61(4):600-3. Epub 2014 Oct 5.

"A. M. and A. Migliavacca" Center for Liver Disease, I Gastroenterology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2014.09.016DOI Listing
December 2014

Non-invasive assessment of liver fibrosis in chronic hepatitis B.

World J Gastroenterol 2014 Oct;20(40):14568-80

Federica Branchi, Clara Benedetta Conti, Alessandra Baccarin, Dario Conte, Mirella Fraquelli, Second Division of Gastroenterology, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, 20122 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i40.14568DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209524PMC
October 2014

Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.

Expert Opin Biol Ther 2014 Jul;14(7):1019-31

Università degli Studi di Milano, Ospedale San Giuseppe, Division of Hepatology , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2014.912273DOI Listing
July 2014

The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.

Int J Mol Sci 2014 Apr 25;15(5):7213-24. Epub 2014 Apr 25.

Division of Gastroenterology and Hepatology, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan 20100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms15057213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057668PMC
April 2014

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?

Liver Int 2014 Feb;34 Suppl 1:120-6

Hepatology Division, Ospedale San Giuseppe, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12401DOI Listing
February 2014

Nucleos(t)ide analogs-based chemoprevention of liver cancer in hepatitis B patients: effective, yet in search of optimization.

Gastroenterology 2013 Nov 19;145(5):1155-6. Epub 2013 Sep 19.

First Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.09.018DOI Listing
November 2013

Tratamiento del virus de la hepatitis B: Cuáles pacientes deberían ser tratados con los análogos de nucleós(t)idos.

Clin Liver Dis (Hoboken) 2013 Nov 13;2(Suppl 5):83-86. Epub 2014 Jan 13.

Centro A. M. ed A. Migliavacca per la Diagnosi e lo Studio delle Malattie del Fegato e delle Vie Biliari, U. O. Gastroenterologia I Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano Milán Italia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cld.280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448673PMC
November 2013

Discontinuation of nucleoside analogues in hepatitis B virus infection.

Gastroenterol Hepatol (N Y) 2013 Oct;9(10):656-8

Assistant Professor 1 st Division of Gastroenterology Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico Università degli Studi di Milano Milan, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992060PMC
October 2013

Results of treatment of chronic hepatitis B with pegylated interferon.

Clin Liver Dis 2013 Aug 3;17(3):425-43. Epub 2013 Jul 3.

Hepatology Division, Ospedale San Giuseppe, Università degli Studi di Milano, Via San Vittore 12, Milano 20123, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2013.05.004DOI Listing
August 2013

PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history.

Expert Rev Anti Infect Ther 2013 May;11(5):459-74

Department of Medicine, A M Migliavacca Center for Liver Diseases and First Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/eri.13.37
Publisher Site
http://dx.doi.org/10.1586/eri.13.37DOI Listing
May 2013